Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations
Pharmaceutics · 09.05.2024 · 16 (5) · 637
DOI: 10.3390/pharmaceutics16050637 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 09.05.2024. Verfasst von Jibira Yakubu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Endocrinology, Diabetology and Metabolism, University Children's Hospital, Inselspital, 3010 Bern, Switzerland. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Cancer League, Swiss Government Excellence Scholarship, CANCER RESEARCH SWITZERLAND.
Abstract (Originalsprache)
Curcumin, a polyphenol with a rich history spanning two centuries, has emerged as a promising therapeutic agent targeting multiple signaling pathways and exhibiting cellular-level activities that contribute to its diverse health benefits. Extensive preclinical and clinical studies have demonstrated its ability to enhance the therapeutic potential of various bioactive compounds. While its reported therapeutic advantages are manifold, predominantly attributed to its antioxidant and anti-inflammatory properties, its efficacy is hindered by poor bioavailability stemming from inadequate absorption, rapid metabolism, and elimination. To address this challenge, nanodelivery systems have emerged as a promising approach, offering enhanced solubility, biocompatibility, and therapeutic effects for curcumin. We have analyzed the knowledge on curcumin nanoencapsulation and its synergistic effects with other compounds, extracted from electronic databases. We discuss the pharmacokinetic profile of curcumin, current advancements in nanoencapsulation techniques, and the combined effects of curcumin with other agents across various disorders. By unifying existing knowledge, this analysis intends to provide insights into the potential of nanoencapsulation technologies to overcome constraints associated with curcumin treatments, emphasizing the importance of combinatorial approaches in improving therapeutic efficacy. Finally, this compilation of study data aims to inform and inspire future research into encapsulating drugs with poor pharmacokinetic characteristics and investigating innovative drug combinations to improve bioavailability and therapeutic outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Endocrinology, Diabetology and Metabolism, University Children's Hospital, Inselspital, 3010 Bern, Switzerland.
- Translational Hormone Research Program, Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland.
- Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.
ORCID-Profile: Amit V Pandey
Förderung
- Swiss Cancer League
- Swiss Government Excellence Scholarship
- CANCER RESEARCH SWITZERLAND
Zitieren
APA
Yakubu, J., & Pandey, A. V. (2024). Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations. Pharmaceutics, 16(5), 637. https://doi.org/10.3390/pharmaceutics16050637
Vancouver
Yakubu J, Pandey AV. Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations. Pharmaceutics. 2024;16(5):637. doi:10.3390/pharmaceutics16050637
BibTeX
@article{Yakubu2024,
author = {Yakubu, Jibira and Pandey, Amit V},
title = {Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {5},
pages = {637},
doi = {10.3390/pharmaceutics16050637}
}
EUVIMED